| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.80M | 33.60M | 20.60M | 10.10M | 14.90M | 18.90M |
| Gross Profit | 28.70M | 24.70M | 1.10M | 2.50M | 7.90M | 800.00K |
| EBITDA | 5.50M | 11.10M | 1.00M | -3.10M | -19.20M | 900.00K |
| Net Income | -10.70M | -12.60M | -13.50M | -9.50M | -23.80M | -11.90M |
Balance Sheet | ||||||
| Total Assets | 95.70M | 77.10M | 78.10M | 25.20M | 26.00M | 40.40M |
| Cash, Cash Equivalents and Short-Term Investments | 4.60M | 3.50M | 2.60M | 1.70M | 600.00K | 2.50M |
| Total Debt | 58.40M | 54.00M | 46.10M | 9.30M | 6.80M | 1.90M |
| Total Liabilities | 92.30M | 79.01M | 71.30M | 17.40M | 21.60M | 16.20M |
| Stockholders Equity | 4.90M | -1.91M | 6.80M | 7.80M | 4.40M | 24.20M |
Cash Flow | ||||||
| Free Cash Flow | 5.80M | -8.10M | -21.20M | -14.10M | -10.00M | -9.30M |
| Operating Cash Flow | 5.80M | 8.80M | -4.30M | -8.30M | -5.80M | -4.60M |
| Investing Cash Flow | -14.80M | -18.60M | -31.20M | -5.60M | -4.30M | -3.10M |
| Financing Cash Flow | 13.10M | 9.30M | 36.80M | 14.70M | 7.50M | 7.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | €98.66M | ― | -0.44% | 6.54% | -14.35% | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
52 Neutral | €63.04M | -4.94 | -4.89% | ― | -4.89% | -178.32% | |
47 Neutral | €14.97M | 7.83 | -0.36% | ― | -4.48% | -105.25% | |
45 Neutral | €539.62M | -1.98 | -4.52% | ― | -11.78% | -28.61% | |
38 Underperform | €6.90M | -0.16 | -78.20% | ― | 90.92% | 24.05% | |
38 Underperform | €64.48M | -2.54 | -514.29% | ― | 63.11% | 10.97% |